Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 441-100-8 | CAS number: 351197-46-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 Apr - 21 Jun 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 441-100-8
- EC Name:
- -
- Cas Number:
- 351197-46-1
- Molecular formula:
- Hill formula: C24 H48 N4 O6 CAS formula: C24 H48 O6 N4
- IUPAC Name:
- 2-[2-(dimethylamino)ethoxy]ethyl N-{[1,3,3-trimethyl-5-(9-methyl-2-oxo-3,6-dioxa-1,9-diazadecan-1-yl)cyclohexyl]methyl}carbamate
- Details on test material:
- - Name of test material (as cited in study report): UAX-1179
- Molecular formula (if other than submission substance): Amber liquid
- Analytical purity: 98.6%
- Lot/batch No.: D07Q028
- Expiration date of the lot/batch: 27 Jul 2012
- Stability under test conditions: Unknown; excluded from the statement of compliance
- Storage condition of test material: At room temperature (range of 20 ± 5°C, provided by Harlan Laboratories Ltd.), light protected
- Safety precautions: Routine hygienic procedures (gloves, goggles, face mask)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: RccHan: WIST (SPF)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Kreuzelweg 53, 5961 NM Horst / The Netherlands
- Age at study initiation: 9 - 10 weeks
- Weight at study initiation: 178.0 g - 199.7 g
- Housing: In groups of three per sex in Makrolon type-4 cages with wire mesh tops and standardized softwood bedding ('Lignocel', J. Rettenmaier&Söhne GmbH&CoKG, 73494 Rosenberg / Germany).
- Diet: Pellet standard Teklad Rat-Mouse Diet 2914C, batch no. 85/10 (Provimi Kliba AG, 4303 Kaiseraugst / Switzerland) ad libitum (except for the overnight fasting period prior to intubation and approximately 3 - 4 hours post dose). Results of analyses for contaminants are archived at Harlan Laboratories Ltd.
- Water: Community tap-water, from ltingen ad libitum. Results of bacteriological, chemical and contaminant analyses are archived at Harlan Ltd, Itingen.
- Acclimation period: 5 to 9 days under laboratory conditions, after health examination. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 - 70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: A preparation of 20% (w/w) in purified water was selected
- Justification for choice of vehicle: Non-GLP solubility trial performed before the study initiation date
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- 300, 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 females
- Control animals:
- no
- Details on study design:
- -Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Daily during acclimatization, prior to treatment, within the first 30 minutes and approximately 1, 2, 3 and 5 hours after treatment on Test day 1 (with the clinical signs) and twice daily during Test days 2 - 15 (Mortality / Viability); on Test days 1 (pre-administration), 8 and 15 (Body weights)
- Frequency of observations: Clinical signs: Daily during acclimatization, prior to treatment, within the first 30 minutes and approximately 1, 2, 3 and 5 hours after treatment on Test day 1. Once daily during Test days 2 -15
- Necropsy of survivors performed: Yes, on all animals treated with 2000 mg/kg bw (Group 2) which died within 1 hour after treatment, a macroscopic examination was performed as soon as they were found dead. All animals treated with 300 mg/kg bw (Groups 1 and 3) were killed at the end of the observation period by carbon dioxide asphyxiation and discarded after macroscopic examinations were performed. An external examination and opening of the abdominal and thoracic cavities for examinations of major organs was performed. The appearance of any macroscopic abnormalities was recorded. No organs or tissues were retained.
- Other examinations performed: clinical signs, body weights, organ weights
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Female: 300 mg/kg bw; Number of animals: 3; Number of deaths: 0
Female: 2000 mg/kg bw; Number of animals: 3; Number of deaths: 3
Female: 300 mg/kg bw; Number of animals: 3; Number of deaths: 0
All animals treated with 2000 mg/kg body weight of the test item died after treatment on Test day 1. All animals treated with 300 mg/kg survived until the end of the study period. - Clinical signs:
- other: All animals treated with 2000 mg/kg bw (Group 2) showed marked shivering, muscle twitching, markedly decreased activity, prostration and marked dyspnea prior to their death within one hour after treatment. Slightly to moderately ruffled fur on Test days 1
- Gross pathology:
- No macroscopic findings were observed at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- harmful, if swallowed
- Executive summary:
In an acute oral toxicity GLP study according to OECD 423, three groups, each consisting of 3 female RccHan:WIST (SPF) rats, were treated by oral gavage with UAX-1179 at 300 (2 groups) and 2000 mg/kg body weight (1 group). The test item was applied in a volume of 10 mL/kg bw. The animals were examined for clinical signs daily during the acclimatization period, five times during Test day 1 and once daily during Test days 2 – 15. Mortality and viability were recorded daily during the acclimatization period and together with clinical signs at the same time intervals on Test day 1 and at least twice daily on Test days 2 – 15. Body weights were recorded on day 1 (prior to administration) and on Days 8 and 15. All animals were necropsied and examined macroscopically. All animals treated with 300 mg/kg bw (Groups 1 and 3) survived the observation period. All animals treated with 2000 mg/kg bw (Group 2) died after treatment on Test day 1. All animals of the highest dose group (2000 mg/kg bw) showed marked shivering, muscle twitching, markedly decreased activity, prostration and marked dyspnea prior to their death within 1 hour after treatment. Animals in Group 1 treated with 300 mg/kg body weight showed slightly to moderately ruffled fur on Test days 1-2. Otherwise, no clinical signs were observed during the course of the study. The body weight of the animals was within the range commonly recorded for this strain and age. No macroscopic findings were observed at necropsy.
The oral LD50 value of UAX-1179 after single administration to female rats, observed over a period of 14 days is considered to be between 300 and 2000 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.